4DMedical creates EU platform via contextflow acquisition
Filed with ASX · · 6 pages · English
Summary by 6ix AI
4DMedical Ltd. has announced the acquisition of contextflow, establishing a European commercial and clinical platform to enhance its operations in the region. This acquisition allows 4DMedical to expand its presence into Europe, complementing its existing operations in North America and ANZ. The acquisition is structured with an upfront cash payment and shares, along with potential performance-based earnouts.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from 4DMedical
- CTVQ enters US Outpatient Market via SimonMed 170 sites
- Major publication validates CTVQ for lung surgery
- GSK contract, UK clearance for CTVQ, and ASX 200 inclusion
- Insignia Financial to be removed from the S&P/ASX 200 Index
- 4DMedical receives CE Mark for CT: VQ™, enabling commercial launch across the European Union
Later from 4DMedical
- 4DMedical targets US$2.5B PE market entry for CTVQ
- 4DMedical receives TGA approval for CTVQ in Australia
- 4DMedical Receives TGA Approval for CT: VQ™, Bringing Non-Contrast Ventilation-Perfusion Imaging to Australia
- Pause in trade
- US Bill directs VA to adopt 4D lung imaging
Follow 4DMedical into a list and get an email when it puts out news.
Follow 4DMedical